189 related articles for article (PubMed ID: 29604905)
1. Oncogenic RAS: From Its Activation to Its Direct Targeting.
Zaravinos A
Crit Rev Oncog; 2017; 22(3-4):283-301. PubMed ID: 29604905
[TBL] [Abstract][Full Text] [Related]
2. The RAS-Effector Interaction as a Drug Target.
Keeton AB; Salter EA; Piazza GA
Cancer Res; 2017 Jan; 77(2):221-226. PubMed ID: 28062402
[TBL] [Abstract][Full Text] [Related]
3. Drugging RAS: Know the enemy.
Papke B; Der CJ
Science; 2017 Mar; 355(6330):1158-1163. PubMed ID: 28302824
[TBL] [Abstract][Full Text] [Related]
4. RAS-targeted therapies: is the undruggable drugged?
Moore AR; Rosenberg SC; McCormick F; Malek S
Nat Rev Drug Discov; 2020 Aug; 19(8):533-552. PubMed ID: 32528145
[TBL] [Abstract][Full Text] [Related]
5. Improving Prospects for Targeting RAS.
Singh H; Longo DL; Chabner BA
J Clin Oncol; 2015 Nov; 33(31):3650-9. PubMed ID: 26371146
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies to target RAS-mutant cancers.
Ryan MB; Corcoran RB
Nat Rev Clin Oncol; 2018 Nov; 15(11):709-720. PubMed ID: 30275515
[TBL] [Abstract][Full Text] [Related]
7. Biology, pathology, and therapeutic targeting of RAS.
Rhett JM; Khan I; O'Bryan JP
Adv Cancer Res; 2020; 148():69-146. PubMed ID: 32723567
[TBL] [Abstract][Full Text] [Related]
8. Direct inhibition of RAS: Quest for the Holy Grail?
Spencer-Smith R; O'Bryan JP
Semin Cancer Biol; 2019 Feb; 54():138-148. PubMed ID: 29248537
[TBL] [Abstract][Full Text] [Related]
9. The greedy nature of mutant RAS: a boon for drug discovery targeting cancer metabolism?
Lv J; Wang J; Chang S; Liu M; Pang X
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):17-26. PubMed ID: 26487443
[TBL] [Abstract][Full Text] [Related]
10. RASpecting the oncogene: New pathways to therapeutic advances.
Stout MC; Campbell PM
Biochem Pharmacol; 2018 Dec; 158():217-228. PubMed ID: 30352234
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in cancer drug discovery targeting RAS.
Wilson CY; Tolias P
Drug Discov Today; 2016 Dec; 21(12):1915-1919. PubMed ID: 27506872
[TBL] [Abstract][Full Text] [Related]
12. Ras proteins as therapeutic targets.
Chakraborty A; Linnane E; Ross S
Biochem Soc Trans; 2018 Oct; 46(5):1303-1311. PubMed ID: 30154091
[TBL] [Abstract][Full Text] [Related]
13. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2017 Jan; 125():299-314. PubMed ID: 27688185
[TBL] [Abstract][Full Text] [Related]
14. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
Dhawan NS; Scopton AP; Dar AC
Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
[TBL] [Abstract][Full Text] [Related]
15. New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics.
Esposito D; Stephen AG; Turbyville TJ; Holderfield M
Semin Cancer Biol; 2019 Feb; 54():174-182. PubMed ID: 29432816
[TBL] [Abstract][Full Text] [Related]
16. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
Sacco E; Spinelli M; Vanoni M
Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
[TBL] [Abstract][Full Text] [Related]
17. Targeting oncogenic Ras signaling in hematologic malignancies.
Ward AF; Braun BS; Shannon KM
Blood; 2012 Oct; 120(17):3397-406. PubMed ID: 22898602
[TBL] [Abstract][Full Text] [Related]
18. Use of retrovirus expression of interfering RNA to determine the contribution of activated K-Ras and ras effector expression to human tumor cell growth.
Baines AT; Lim KH; Shields JM; Lambert JM; Counter CM; Der CJ; Cox AD
Methods Enzymol; 2006; 407():556-74. PubMed ID: 16757353
[TBL] [Abstract][Full Text] [Related]
19. The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications.
Delire B; Stärkel P
Eur J Clin Invest; 2015 Jun; 45(6):609-23. PubMed ID: 25832714
[TBL] [Abstract][Full Text] [Related]
20. Targeting RAS-ERK signalling in cancer: promises and challenges.
Samatar AA; Poulikakos PI
Nat Rev Drug Discov; 2014 Dec; 13(12):928-42. PubMed ID: 25435214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]